Joseph M. Wiley

Dr. Wiley is Vice President, Medical Affairs, Drug Safety, and Pharmacovigilance at Leadiant Biosciences, Inc. and is responsible for leading and managing Leadiant’s medical affairs operations and the drug safety and pharmacovigilance activities. Dr. Wiley directs the medical affairs strategic and operational initiatives and the medical science liaison team, as well as providing medical and scientific support of Clinical and Regulatory Affairs. Dr. Wiley supervises the drug safety team to monitor post approval adverse drug effects of the organization’s pharmaceutical portfolio. Dr. Wiley is responsible for managing the safety updates and maintenance of the safety components of the drug label. He has more than 35 years of experience and leadership in the medical field, specifically in pediatric hematology-oncology.

Prior to joining Leadiant, he served as the first Medical Director of Population Health at LifeBridge Health in Baltimore, Maryland after serving as Chairman of Pediatrics for 14 years. Previously, he has also served as the Interim Director, Cancer Institute at the Alvin and Lois Lapidus Cancer Institute, Chairman of the Medical Executive Committee, Chairman of the Institutional Review Board and Chief of the Division of Pediatric Hematology-Oncology at Sinai Hospital of Baltimore.

Dr. Wiley has contributed to more than one hundred publications and was honored as Pediatrician of the Year, Maryland Chapter, of the American Academy of Pediatrics in 2013. He received his Bachelor of Arts in mathematics from Loyola College and his M.D. from the University Of Maryland School Of Medicine. He completed his pediatric residency at The John Hopkins Hospital and a fellowship training in pediatric hematology oncology and bone marrow transplantation at The Johns Hopkins University, School of Medicine and Johns Hopkins Hospital. Dr. Wiley is a member of numerous scientific societies and serves as a board member for the Children’s Cancer Foundation in Maryland.